These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 20970608
1. Pneumonitis associated with mammalian target of rapamycin inhibitors in renal transplant recipients: a single-center experience. Errasti P, Izquierdo D, Martín P, Errasti M, Slon F, Romero A, Lavilla FJ. Transplant Proc; 2010 Oct; 42(8):3053-4. PubMed ID: 20970608 [Abstract] [Full Text] [Related]
2. Comparative analysis of adverse events requiring suspension of mTOR inhibitors: everolimus versus sirolimus. Sánchez-Fructuoso AI, Ruiz JC, Pérez-Flores I, Gómez Alamillo C, Calvo Romero N, Arias M. Transplant Proc; 2010 Oct; 42(8):3050-2. PubMed ID: 20970607 [Abstract] [Full Text] [Related]
10. Everolimus: a proliferation signal inhibitor with clinical applications in organ transplantation, oncology, and cardiology. Gabardi S, Baroletti SA. Pharmacotherapy; 2010 Oct; 30(10):1044-56. PubMed ID: 20874042 [Abstract] [Full Text] [Related]
11. Interstitial pneumonitis as an adverse reaction to mTOR inhibitors. Molas-Ferrer G, Soy-Muner D, Anglada-Martínez H, Riu-Viladoms G, Estefanell-Tejero A, Ribas-Sala J. Nefrologia; 2013 Oct; 33(3):297-300. PubMed ID: 23712219 [Abstract] [Full Text] [Related]
14. Everolimus- and temsirolimus-associated enteritis: report of three cases. Parithivel K, Ramaiya N, Jagannathan JP, O'Regan K, Krajewski K, Fisher D, Choueiri TK, Jacobsen E. J Clin Oncol; 2011 May 10; 29(14):e404-6. PubMed ID: 21357780 [No Abstract] [Full Text] [Related]
15. Switch to everolimus for sirolimus-induced pneumonitis in a liver transplant recipient--not all proliferation signal inhibitors are the same: a case report. De Simone P, Petruccelli S, Precisi A, Carrai P, Doria R, Menichetti F, Filipponi F. Transplant Proc; 2007 Dec 10; 39(10):3500-1. PubMed ID: 18089420 [Abstract] [Full Text] [Related]
16. Sirolimus-induced pneumonitis following liver transplantation. Roberts RJ, Wells AC, Unitt E, Griffiths M, Tasker AD, Allison ME, Bradley JA, Watson CJ. Liver Transpl; 2007 Jun 10; 13(6):853-6. PubMed ID: 17539005 [Abstract] [Full Text] [Related]
17. Regression of left ventricular hypertrophy in kidney transplant recipients: the potential role for inhibition of mammalian target of rapamycin. Paoletti E, Cannella G. Transplant Proc; 2010 Nov 10; 42(9 Suppl):S41-3. PubMed ID: 21095451 [Abstract] [Full Text] [Related]
18. Proteinuria associated with mTOR inhibitors after kidney transplant. Guney M, Sahin G, Yilmaz B, Canbakan M, Gucun M, Kayatas K, Eren P, Titiz I. Exp Clin Transplant; 2014 Dec 10; 12(6):539-42. PubMed ID: 25489805 [Abstract] [Full Text] [Related]
19. Interstitial pneumonitis caused by everolimus: a case-cohort study in renal transplant recipients. Baas MC, Struijk GH, Moes DJ, van den Berk IA, Jonkers RE, de Fijter JW, van der Heide JJ, van Dijk M, ten Berge IJ, Bemelman FJ. Transpl Int; 2014 May 10; 27(5):428-36. PubMed ID: 24484452 [Abstract] [Full Text] [Related]
20. Severe everolimus-associated pneumonitis in a renal transplant recipient. Alexandru S, Ortiz A, Baldovi S, Milicua JM, Ruíz-Escribano E, Egido J, Plaza JJ. Nephrol Dial Transplant; 2008 Oct 10; 23(10):3353-5. PubMed ID: 18658177 [Abstract] [Full Text] [Related] Page: [Next] [New Search]